GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.10.17	CDC's Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up (PR Newswire)
25.10.17	GlaxoSmithKline Q3 Profit Rises; Affirms FY Outlook (RTTNews)
25.10.17	GlaxoSmithKline Q3 Pre-tax Profit Rises; Backs FY Adj. EPS Growth View (RTTNews)
23.10.17	DBVT Disappoints, GSK Gets Greenlight, AIMT Catches Eyes, FDA Snubs ATRS (RTTNews)
21.10.17	Shingrix approved in the US for prevention of shingles in adults aged 50 and over (PR Newswire)
09.10.17	New Drugs Approved In September (RTTNews)
29.09.17	Biotech Stocks Facing FDA Decision In October (RTTNews)
19.09.17	FDA Okays GSK's Three-in-one Drug Inhaler For COPD (RTTNews)
19.09.17	Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US (PR Newswire)
18.09.17	FDA Nod For NEOS, One Step Closer To EU Approval Are GSK, TSRO, On Watch Is MTFB (RTTNews)
15.09.17	GSK, Innoviva: Trelegy Ellipta Gets CHMP Positive Opinion In Europe For COPD (RTTNews)
14.09.17	FDA Panel Nod For GSK's Shingles Vaccine, FOLD Beyond Essence, FENC Is Red Hot (RTTNews)
14.09.17	GSK Announces Unanimous FDA Approval For Shingrix In Over 50s - Quick Facts (RTTNews)
13.09.17	FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over (PR Newswire)
12.09.17	GSK Publishes Results Of Phase III Studies For Mepolizumab In COPD (RTTNews)
07.09.17	Adaptimmune: GSK Exercises Option Over NY-ESO SPEAR T-Cell Therapy Program (RTTNews)
29.08.17	Biotech Stocks Facing FDA Decision In September (RTTNews)
29.08.17	Technical Reports on Drug Makers Equities -- Impax Labs, GlaxoSmithKline, Novartis, and TherapeuticsMD (PR Newswire)
24.08.17	Propeller Health Expands Its Collaboration With GSK - Quick Facts (RTTNews)
11.08.17	Ionis Retains All Rights To Inotersen, IONIS-FB-L Rx; GSK Declines Its Options (RTTNews)
03.08.17	Company Spotlight: Dynavax (RTTNews)
03.08.17	FDA Panel Snubs JNJ, CHMP Seeks More Data From PBYI, TBPH On Watch, AGRX Slumps (RTTNews)
31.07.17	Biotech Stocks Facing FDA Decision In August (RTTNews)
26.07.17	Jeremy Halford Joins Tiger Group as Managing Director of Commercial & Industrial Division (PR Newswire)
26.07.17	GlaxoSmithKline Q2 Loss Narrows; Reiterates Outlook To 2020 - Quick Facts (RTTNews)
25.07.17	ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings (PR Newswire)
25.07.17	ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings (PR Newswire)
25.07.17	ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings (PR Newswire)
25.07.17	ViiV Healthcare Reports Positive Interim Results From DAWNING - Quick Facts (RTTNews)
25.07.17	GSK : ViiV Healthcare Announces Results From NEAT 022 Study (RTTNews)
24.07.17	GlaxoSmithKline: ViiV Healthcare Presents 96-week Data From LATTE-2 Study (RTTNews)
21.07.17	GSK Submits EU Filing For Extended Use Of Relvar Ellipta (RTTNews)
20.07.17	Technical Reports on Drug Makers Equities -- TherapeuticsMD, GlaxoSmithKline, Novartis, and Impax Labs (PR Newswire)
14.07.17	GSK ships 2017-18 seasonal influenza vaccines for US market (PR Newswire)
02.07.17	Exscientia Enters Strategic Drug Discovery Collaboration With GSK (RTTNews)
27.06.17	GlaxoSmithKline Begins Mepolizumab Phase III Study - Quick Facts (RTTNews)
21.06.17	GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting (PR Newswire)
20.06.17	GSK Confirms Start Date For Luke Miels As President, Global Pharma (RTTNews)
16.06.17	Stocks Under Scanner in the Drug Makers Space -- TherapeuticsMD, GlaxoSmithKline, Novartis, and Tonix Pharma (PR Newswire)
02.06.17	GSK Reports EU & US Submissions For First HIV Maintenance Regimen - Quick Facts (RTTNews)
08.05.17	How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Perrigo, and BioScrip (PR Newswire)
05.05.17	GSK And Innoviva Announce Positive Results From SLS In Asthma (RTTNews)
25.04.17	Ellington Residential Mortgage REIT Announces Release Date of First Quarter 2017 Earnings, Conference Call, and Investor Presentation (PR Newswire)
18.04.17	GlaxoSmithKline JV Submits NDA For Candidate Shingles Vaccine Shingrix In Japan (RTTNews)
31.03.17	How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Universal Health Services, Shire, and LifePoint Health (PR Newswire)
30.03.17	FDA Snubs MYL, Roche Wins FDA Panel Vote Hands Down, TNXP Falls After-hours (RTTNews)
15.03.17	GlaxoSmithKline's New Woman CEO To Make Less Than Male Predecessor (RTTNews)
15.03.17	GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older (PR Newswire)
07.03.17	NOVN Moves Ahead, PTCT Finally Achieves It, TGTX Gets GENUINE Reaction (RTTNews)
06.03.17	GSK's MUSCA study shows Nucala® (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft